Skip to main content
. Author manuscript; available in PMC: 2024 Jan 17.
Published in final edited form as: Drug Dev Res. 1996 Nov-Dec;39(3-4):253–261. doi: 10.1002/(sici)1098-2299(199611/12)39:3/4<253::aid-ddr4>3.0.co;2-q
Strategy, Management and Health Policy
Venture Capital Enabling Technology Preclinical Research Preclinical Development Toxicology, Formulation Drug Delivery, Pharmacokinetics Clinical Development Phases I-III Regulatory, Quality, Manufacturing Postmarketing Phase IV